Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A(4) hydrolase

Research output: Contribution to journalArticle


Leukotriene B-4 (LTB4) is a potent pro-inflammatory mediator that has been implicated in the pathogenesis of multiple diseases, including psoriasis, inflammatory bowel disease, multiple sclerosis and asthma. As a method to decrease the level of LTB4 and possibly identify novel treatments, inhibitors of the LTB4 biosynthetic enzyme, leukotriene A(4) hydrolase (LTA(4)-h), have been explored. Here we describe the discovery of a potent inhibitor of LTA(4)-h, arylamide of glutamic acid 4f, starting from the corresponding glycinamide 2. Analogs of 4f are then described, focusing on compounds that are both active and stable in whole blood. This effort culminated in the identification of amino alcohol 12a and amino ester 6b which meet these criteria.


  • Thomas A. Kirkland
  • Marc Adler
  • John G. Bauman
  • Ming Chen
  • Jesper Z. Haeggstrom
  • Beverly King
  • Monica J. Kochanny
  • Amy M. Liang
  • Lisa Mendoza
  • Gary B. Phillips
  • Marjolein Thunnissen
  • Lan Trinh
  • Marc Whitlow
  • Bin Ye
  • Hong Ye
  • John Parkinson
  • William J. Guilford
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Biological Sciences


  • leukotriene A4, inhibitor, crystal structure
Original languageEnglish
Pages (from-to)4963-4983
JournalBioorganic & Medicinal Chemistry
Issue number9
Publication statusPublished - 2008
Publication categoryResearch